CORESTEMCHEMON Inc.

Company Profile

Sector

Healthcare

Industry

Biotechnology

Employees

N/A

Website

www.corestem.com

Country

South Korea

Exchange

KOSDAQ

Founded 2003

CORESTEMCHEMON Inc., a bio-pharmaceutical company provides the development and production of stem cell therapies for the treatment of incurable diseases in South Korea. It offers NEURONATA-R inj, an autologous bone marrow mesenchymal stem cell therapy for the treatment of amyotrophic lateral sclerosis (ALS)

The development of various therapy products for the treatment of systemic lupus erythematosus (SLE), multiple system atrophy (MSA), and cerebellar ataxia (CA) diseases. The company has a strategic partnership with ATG Lifetech to deliver precision-driven non-clinical solutions to pharmaceutical companies and biotech ventures. Founded in 2003, The company was formerly known as Corestem, Inc. CORESTEMCHEMON is based in Seongnam-si, South Korea.

Key Stats

52-Week Range

₩1014.00₩6100.00

Beta1.52

Trailing P/EN/A

Forward P/EN/A

Trailing EPSN/A

Avg Volume

Earnings & Analyst

Next EarningsN/A

EPS EstimateN/A

Target Mean PriceN/A

RecommendationNone

Recommendation MeanN/A

Recent SEC Filings

SEC filings for this ticker are not available yet.